Document:

IntelGenx Technologies Corp. - Exhibit 10.5 - Filed by newsfilecorp.com

Exhibit 10.5

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF
THE SECURITIES REPRESENTED HEREBY SHALL NOT TRADE SUCH SECURITIES BEFORE
DECEMBER 28, 2010. RIGHTS TO TRANSFER AND ASSIGN THE SECURITIES REPRESENTED
HEREBY ARE FURTHER RESTRICTED BY THE TERMS HEREOF. 

THIS CERTIFICATE WILL BE VOID AND OF NO VALUE UNLESS
EXERCISED ON OR BEFORE 5:00 P.M. (TORONTO TIME) ON THE EXPIRY TIME (AS HEREIN
DEFINED). 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR
UNDER ANY STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING THESE
SECURITIES, AGREES FOR THE BENEFIT OF INTELGENX TECHNOLOGIES CORP. (THE
“COMPANY”) THAT THESE SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE
TRANSFERRED, DIRECTLY OR INDIRECTLY, ONLY (A) TO THE COMPANY, (B) IN COMPLIANCE
WITH (I) RULE 144A UNDER THE 1933 ACT, IF APPLICABLE, TO A PERSON WHO THE SELLER
REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A)
THAT IS PURCHASING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED
INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE OFFER, SALE OR TRANSFER IS
BEING MADE IN RELIANCE OF RULE 144A, OR (II) RULE 144 UNDER THE 1933 ACT, IF
APPLICABLE, AND, IN EACH CASE, IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS, OR (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE 1933
ACT AND ANY APPLICABLE STATE SECURITIES LAWS, AND, IN THE CASE OF (C)(II) AND
(D), THE SELLER FURNISHES TO THE COMPANY AN OPINION OF COUNSEL OF RECOGNIZED
STANDING IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY TO SUCH EFFECT.
DELIVERY OF THIS CERTIFICATE MAY NOT CONSTITUTE “GOOD DELIVERY” IN SETTLEMENT OF
TRANSACTIONS ON STOCK EXCHANGES IN CANADA. HEDGING TRANSACTIONS INVOLVING THE
SECURITIES ARE PROHIBITED EXCEPT IN COMPLIANCE WITH THE 1933 ACT. 

THIS WARRANT HAS NOT BEEN AND WILL NOT BE, AND THE SHARES
ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN, REGISTERED UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"), OR THE SECURITIES LAWS OF
ANY STATE OF THE UNITED STATES. THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED
STATES OR BY OR FOR THE ACCOUNT OR BENEFIT OF A U.S. PERSON OR PERSON IN THE
UNITED STATES AND THE UNDERLYING SHARES MAY NOT BE DELIVERED WITHIN THE UNITED
STATES UNLESS THE WARRANT AND THE UNDERLYING SHARES HAVE BEEN REGISTERED UNDER
THE 1933 ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR UNLESS AN EXEMPTION
FROM SUCH REGISTRATION REQUIREMENTS IS AVAILABLE, AND THE HOLDER HAS DELIVERED
AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE
CORPORATION TO SUCH EFFECT. "UNITED STATES" AND "U.S. PERSON" ARE USED HEREIN AS
SUCH TERMS ARE DEFINED BY REGULATION S UNDER THE 1933 ACT. 

AUGUST 27, 2010 
INTELGENX TECHNOLOGIES CORP.

a corporation incorporated under the laws of Delaware 
and having
its principal office at 
6425 Abrams 
Ville St-Laurent, Quebec

  H4S 1X9 

	NO. BW-1	 [•] BROKER WARRANTS 
		
      Each entitling the holder to acquire one (1)
      Share (as defined herein) of IntelGenx Technologies
      Corp., subject to adjustment in certain circumstances.
    

- 2 - 

BROKER WARRANTS 

THIS IS TO CERTIFY THAT for value received • (the
“Holder”) is the registered holder of the number of Broker Warrants
stated above and is entitled, for each whole Broker Warrant represented hereby,
to purchase one common share (“Share”) of IntelGenx Technologies Corp.
(the “Corporation”) at any time from the date of issue hereof up to and
including 5:00 p.m. (Toronto Time) on August 28, 2012 (the “Expiry Time”)
at a price per Share equal to CAD$0.50 (the “Exercise Price”), upon and
subject to the following terms and conditions. 

Capitalized terms used herein without definition have the
meanings ascribed thereto in the Agency Agreement dated August 27, 2010 between
the Corporation and Bolder Investment Partners, Ltd. 

	1. 	
      The Broker Warrants represented by this Broker Warrant
      Certificate may not be exercised in the United States or by or for the
      account or benefit of a U.S. Person or person in the United States nor
      will the Shares issuable upon exercise of these Broker Warrants be
      registered or delivered to an address in the United States, unless the
      Shares issuable upon exercise of these Warrants have been registered in
      accordance with the United States Securities Act of 1933, as amended (the
      “U.S. Securities Act”) and any applicable securities laws of any
      state of the United States or an exemption from such registration
      requirements is available, and the Corporation receives an opinion of
      counsel to such effect in form and substance satisfactory to it. As used
      herein, the terms “United States” and “U.S. Person” have the meanings
      ascribed to them in Regulation S under the U.S. Securities Act.

	 	 
		
      The Broker Warrants represented by this Broker Warrant
      Certificate and the Shares issuable upon exercise of these Broker Warrants
      are subject to certain resale restrictions under applicable securities
      legislation and unless permitted under securities legislation and subject
      to Section 15 hereof, the Broker Warrants and the Shares may not be traded
      before December 28, 2010. The Holder is advised to seek professional
      advice as to applicable resale restrictions.

	 	 
		
      Certificates representing the Shares issuable upon the
      exercise of these Broker Warrants shall bear a legend until the expiration
      of the hold period indicating that they may not be traded before December
      28, 2010.

	 	 
	2. 	
      At any time, or from time to time, at or prior to the
      Expiry Time (the “Exercise Period”), the Holder may exercise all or
      any number of whole Broker Warrants represented hereby, upon delivering to
      the Corporation at its principal office noted above this Broker Warrant
      Certificate, together with a duly completed and executed subscription
      notice in the form attached hereto (the “Subscription Notice”)
      evidencing the election (which on delivery to the Corporation shall be
      irrevocable) of the Holder to exercise the number of Broker Warrants set
      forth in the Subscription Notice (which shall not be greater than the
      number of Broker Warrants represented by this Broker Warrant Certificate
      and a certified cheque or bank draft payable to the Corporation for the
      aggregate Exercise Price of all Broker Warrants being exercised. If the
      Holder is not exercising all Broker Warrants represented by this Broker
      Warrant Certificate, the Holder shall be entitled to receive, without
      charge, a new Broker Warrant Certificate representing the number of Broker
      Warrants which is the difference between the number of Broker Warrants
      represented by the then original Broker Warrant Certificate and the number
      of Broker Warrants being so exercised.

	 	 
	3. 	
      The Holder shall be deemed to have become the holder of
      record of Shares on the date (the “Exercise Date”) on which the
      Corporation has received a duly completed Subscription Notice, delivery of
      the Broker Warrant Certificate and payment in full in respect of the
      Shares by way of a certified cheque, bank draft or money order in lawful
      money of Canada payable to the order of IntelGenx Technologies Corp. or
      its successor corporation; provided, however, that if such date is not a
      business day in the City of Toronto, Ontario, the City of Montreal, Quebec
      or a statutory holiday in the United States of America (a “Business
      Day”) then the Shares shall be deemed to have been issued and the
      Holder shall be deemed to have become the holder of record of the Shares
      on the next following Business Day. Within three (3) Business Days of the
      Exercise Date, the Corporation shall issue and deliver (or cause to be
      delivered) to the Holder, by registered mail or pre-paid courier to his,
      her or its address specified in the register of the Corporation, one or
      more certificates for the appropriate number of issued and outstanding
      Shares.

- 3 - 

	4. 	
      The Corporation covenants and agrees that, until the
      Expiry Time, while any of the Broker Warrants represented by this Broker
      Warrant Certificate shall be outstanding; (a) it shall reserve and there
      shall remain unissued out of its authorized capital a sufficient number of
      Shares to satisfy the right of purchase herein provided (b) all Shares
      which shall be issued upon the exercise of the right to purchase herein
      provided for, upon payment therefor of the amount at which such Shares may
      at the time be purchased pursuant to the provisions hereof, shall be
      issued as fully paid and non-assessable shares and the holders thereof
      shall not be liable to the Corporation or its creditors in respect
      thereof; (c) the Corporation shall make all requisite filings under the
      Securities Act (Ontario) and the regulations made thereunder
      including those necessary to remain a reporting issuer not in default of
      any requirement of such act and regulations; and (d) the Corporation shall
      use all reasonable efforts to preserve and maintain its corporate
      existence.

	 	 
	5. 	
      The Exercise Price and the number of Shares purchasable
      upon exercise shall be subject to adjustment from time to time in the
      events and in the manner provided as follows:

	 	(a) 	
      Share Reorganization. If during the Exercise
      Period the Corporation shall:

	 	 	 	 
	 		(i) 	
      issue Shares or securities exchangeable for or
      convertible into Shares to holders of all or substantially all of its then
      outstanding Shares by way of stock dividend or other distribution,
    or

	 	 	 	 
	 		(ii) 	
      subdivide, redivide or change its outstanding Shares into
      a greater number of Shares, or

	 	 	 	 
	 		(iii) 	
      consolidate, reduce or combine its outstanding Shares
      into a lesser number of Shares,

	 		
      (any of such events in these paragraphs (i), (ii) and
      (iii) being a “Share Reorganization”), then the Exercise Price
      shall be adjusted as of the effective date or record date, as the case may
      be, at which the holders of Shares are determined for the purpose of the
      Share Reorganization by multiplying the Exercise Price in effect
      immediately prior to such effective date or record date by a fraction, the
      numerator of which shall be the number of Shares outstanding on such
      effective date or record date before giving effect to such Share
      Reorganization and the denominator of which shall be the number of Shares
      outstanding as of the effective date or record date after giving effect to
      such Share Reorganization (including, in the case where securities
      exchangeable for or convertible into Shares are distributed, the number of
      Shares that would have been outstanding had such securities been fully
      exchanged for or converted into Shares on such record date or effective
      date). From and after any adjustment of the Exercise Price pursuant to
      this Section 5(a), the number of Shares purchasable pursuant to this
      Broker Warrant Certificate shall be adjusted contemporaneously with the
      adjustment of the Exercise Price by multiplying the number of Shares then
      otherwise purchasable on the exercise thereof by a fraction, the numerator
      of which shall be the Exercise Price in effect immediately prior to the
      adjustment and the denominator of which shall be the Exercise Price
      resulting from such adjustment.

	 	 	 
	 	(b) 	
      Rights Offering. If and whenever during the
      Exercise Period the Corporation shall fix a record date for the issue of
      rights, options or warrants to all or substantially all of the holders of
      Shares under which such holders are entitled, during a period expiring not
      more than 45 days after the record date for such issue (“Rights
      Period”), to subscribe for or purchase Shares or securities
      exchangeable for or convertible into Shares at a price per share to the
      holder (or having a conversion price or exchange price per Share) of less
      than 95% of the Current Market Price (as defined in Section 6 hereof) for
      the Shares on such record date (any of such events being called a
      “Rights Offering”), then the Exercise Price shall be adjusted
      effective immediately after the end of the Rights Period to a price
      determined by multiplying the Exercise Price in effect immediately prior
      to the end of the Rights Period by a fraction:

	 	(i) 	
      the numerator of which shall be the aggregate
  of:

- 4 - 

	 	(A) 	
      the number of Shares outstanding as of the record date
      for the Rights Offering, and

	 	 	 
	 	(B) 	
      a number determined by dividing
either

	 	I. 	
      the product of the number of Shares issued or subscribed
      for during the Rights Period and the price at which such Shares are
      offered,

or, as the case may be, 

	 	II. 	
      the product of the exchange or conversion price per share
      of such securities offered and the number of Shares for or into which the
      securities so offered pursuant to the Rights Offering have been exchanged
      or converted during the Rights Period,

by the Current Market Price of the
Shares as of the record date for the Rights Offering; and 

	 	(ii) 	
      the denominator of which shall be the number of Shares
      outstanding after giving effect to the Rights Offering and including the
      number of Shares actually issued or subscribed for during the Rights
      Period upon exercise of the rights, warrants or options under the Rights
      Offering or upon the exercise of the exchange or conversion rights
      contained in such exchangeable or convertible securities under the Rights
      Offering.

	 		
      If the Holder has exercised any of the Broker Warrants
      during the period beginning immediately after the record date for a Rights
      Offering and ending on the last day of the Rights Period, the Holder
      shall, in addition to the Shares to which the Holder is otherwise entitled
      upon such exercise in accordance with Section 2 hereof, be entitled to
      that number of additional Shares equal to the result obtained when the
      difference, if any, resulting from the subtraction of the Exercise Price
      as adjusted for such Rights Offering pursuant to this Section 5(b) from
      the Exercise Price in effect immediately prior to the end of such Rights
      Offering is multiplied by the number of Shares purchased upon exercise of
      the Broker Warrants held by such Holder during such period, and the
      resulting product is divided by the Exercise Price as adjusted for such
      Rights Offering pursuant to this Section 5(b); provided that the
      provisions of Section 9 shall be applicable to any fractional interest in
      a Share to which such Holder might otherwise be entitled under the
      foregoing provisions of this Section 5(b). Such additional Shares shall be
      deemed to have been issued to the Holder immediately following the end of
      the Rights Period and a certificate for such additional Shares shall be
      delivered to such Holder within three (3) Business Days following the end
      of the Rights Period.

	 	 	 	 
	 	(c) 	
      Special Distribution. If and whenever during the
      Exercise Period the Corporation shall issue or distribute to all or to
      substantially all the holders of the Shares:

	 	 	 	 
	 		(i) 	
      securities of the Corporation including shares, rights,
      options or warrants to acquire shares of any class or securities
      exchangeable for or convertible into or exchangeable into any such shares
      or cash, property or assets and including evidences of its indebtedness,
      or

	 	 	 	 
	 		(ii) 	
      any cash, property or other assets,

	 	 	 	 
	 			
      and if such issuance or distribution does not constitute
      dividends paid in the ordinary course, a Share Reorganization or a Rights
      Offering (any of such non-excluded events being herein called a
      “Special Distribution”), the number of Shares to be issued by the
      Corporation under the Broker Warrants shall, at the time of exercise, be
      appropriately adjusted and the Holder shall receive, in lieu of the number
      of Shares in respect of which the right is then being exercised, the
      aggregate number of Shares or other securities or property that the Holder
      would have been entitled to receive as a result of such event if, on the record date
      therefor, the Holder had been the registered holder of the number of
      Shares to which the Holder was theretofore entitled upon the exercise of
      the Broker Warrants.

- 5 - 

	 	(d) 	
      Capital Reorganization. If and whenever during the
      Exercise Period there shall be a reclassification of Shares at any time
      outstanding or a change of the Shares into other shares or into other
      securities (other than a Share Reorganization), or a consolidation,
      amalgamation, arrangement or merger of the Corporation with or into any
      other corporation or other entity (other than a consolidation,
      amalgamation, arrangement or merger which does not result in any
      reclassification of the outstanding Shares or a change of the Shares into
      other securities), or a transfer of the undertaking or assets of the
      Corporation as an entirety or substantially as an entirety to another
      corporation or other entity (any of such events being herein called a
      “Capital Reorganization”), the Holder, where he has not exercised the
      right of subscription and purchase under this Broker Warrant Certificate
      prior to the effective date or record date, as the case may be, of such
      Capital Reorganization, shall be entitled to receive, and shall accept
      upon the exercise of such right for the same aggregate consideration, in
      lieu of the number of Shares to which such holder was theretofore entitled
      upon such exercise, the aggregate number of shares, other securities or
      other property which such holder would have been entitled to receive as a
      result of such Capital Reorganization if, on the effective date thereof,
      he had been the registered holder of the number of Shares to which such
      holder was theretofore entitled to subscribe for and purchase; provided
      however, that no such Capital Reorganization shall be carried into effect
      unless all necessary steps shall have been taken to so entitle the Holder.
      If determined appropriate by the board of directors of the Corporation,
      acting reasonably and in good faith, and subject to the prior written
      approval of the principal Canadian stock exchange or over-the-counter
      market on which the Shares are then listed or quoted for trading,
      appropriate adjustments shall be made as a result of any such Capital
      Reorganization in the application of the provisions set forth in this
      Section 5 with respect to the rights and interests thereafter of the
      Holder to the end that the provisions set forth in this Section 5 shall
      thereafter correspondingly be made applicable as nearly as may reasonably
      be in relation to any shares, other securities or other property
      thereafter deliverable upon the exercise of any Broker Warrant.

	 	 	 
	 	(e) 	
      If and whenever at any time after the date hereof and
      prior to the Expiry Time, the Corporation takes any action affecting its
      Shares to which the foregoing provisions of this Section 5, in the
      opinion of the board of directors of the Corporation, acting reasonably
      and in good faith, are not strictly applicable, or if strictly applicable
      would not fairly adjust the rights of the Holder against dilution in
      accordance with the intent and purposes thereof, or would otherwise
      materially affect the rights of the Holder hereunder, then the Corporation
      shall execute and deliver to the Holder an amendment hereto providing for
      an adjustment in the application of such provisions so as to adjust such
      rights as aforesaid in such a manner as the board of directors of the
      Corporation may determine to be equitable in the circumstances, acting
      reasonably and in good faith. The failure of the taking of action by the
      board of directors of the Corporation to so provide for any adjustment on
      or prior to the effective date of any action or occurrence giving rise to
      such state of facts will be conclusive evidence that the board of
      directors has determined that it is equitable to make no adjustment in the
      circumstances.

	6. 	
      The following rules and procedures shall be applicable to
      the adjustments made pursuant to Section 5:

	 	 	 
		(a) 	
      The adjustments provided for in Section 5 are cumulative,
      and shall, in the case of adjustments to the Exercise Price be computed to
      the nearest one-tenth of one cent and shall be made successively whenever
      an event referred to therein shall occur, subject to the following
      paragraphs of this Section 6.

	 	 	 
		(b) 	
      No adjustment in the Exercise Price shall be required
      unless such adjustment would result in a change of at least 1% in the
      prevailing Exercise Price and no adjustment shall be made in the number of
      Shares purchasable upon exercise of this Broker Warrant unless it would
      result in a change of at least one one-hundredth of a Share; provided,
      however, that any adjustments which, except for the provisions of this Section 6(b) would
      otherwise have been required to be made, shall be carried forward and
      taken into account in any subsequent adjustment.

- 6 - 

	 	(c) 	
      No adjustment in the Exercise Price or in the number of
      Shares purchasable upon exercise of Broker Warrants shall be made in
      respect of any event described in Section 5, other than the events
      referred to in Sections 5(a)(ii) and (iii), if the Holder is entitled to
      participate in such event on the same terms, mutatis mutandis, as
      if it had exercised its Broker Warrants prior to or on the effective date
      or record date of such event. The terms of the participation of the Holder
      in such event shall be subject to the prior written approval of the
      principal Canadian stock exchange or over-the-counter market on which the
      Shares are then listed or quoted for trading.

	 	 	 	 
	 	(d) 	
      No adjustment in the Exercise Price shall be made
      pursuant to Section 5 in respect of the issue from time to time:

	 	 	 	 
	 		(i) 	
      of Shares purchasable on exercise of the Broker Warrants
      represented by or issued concurrently with this Broker Warrant
      Certificate;

	 	 	 	 
	 		(ii) 	
      of dividends paid in the ordinary course on Shares to
      holders of Shares who exercise an option or election to receive
      substantially equivalent dividends in the form of Shares in lieu of
      receiving a cash dividend pursuant to a dividend reinvestment plan or
      similar plan adopted by the Corporation in accordance with the
      requirements of the principal Canadian stock exchange or over-the-counter
      market on which the Shares are then listed or quoted for trading and
      applicable securities laws;

	 	 	 	 
	 		(iii) 	
      of Shares pursuant to any stock option plan, stock
      purchase plan or benefit plan in force at the date hereof for directors,
      officers, employees, advisers or consultants of the Corporation, as such
      option or plan is amended or superseded from time to time in accordance
      with the requirements of the principal Canadian stock exchange or
      over-the- counter market on which the Shares are then listed or quoted for
      trading and applicable securities laws, and such other stock option plan,
      stock purchase plan or benefit plan as may be adopted by the Corporation
      in accordance with the requirements of the principal Canadian stock
      exchange or over-the-counter market on which the Shares are then listed or
      quoted for trading and applicable securities laws;

	 	 	 	 
	 		(iv) 	
      the payment of interest on any outstanding
  notes;

	 	 	 	 
	 		(v) 	
      the issuance of securities in connection with strategic
      license agreements and other partnering arrangements; or

	 	 	 	 
	 		(vi) 	
      full or partial consideration in connection with a
      strategic merger, consolidation or purchase of substantially all of the
      securities or assets of a corporation or other entity;

	 	 	 	 
	 			
      and any such issue shall be deemed not to be a Share
      Reorganization or Capital Reorganization.

	 	 	 	 
	 	(e) 	
      If the Corporation shall set a record date to determine
      the holders of the Shares for the purpose of entitling them to receive any
      dividend or distribution or any subscription or purchase rights and shall,
      thereafter and before the distribution to such shareholders of any such
      dividend, distribution or subscription or purchase rights, legally abandon
      its plan to pay or deliver such dividend, distribution or subscription or
      purchase rights, then no adjustment in the Exercise Price or the number of
      Shares purchasable upon exercise of any Broker Warrant shall be required
      by reason of the setting of such record date.

	 	 	 	 
	 	(f) 	
      As a condition precedent to the taking of any action
      which would require any adjustment in any of the subscription rights
      pursuant to this Broker Warrant Certificate, including the Exercise Price
      and the number or class of shares or other securities which are to be
      received upon the exercise thereof, the Corporation shall take any corporate action
      which may be necessary in order that the Corporation have unissued and
      reserved in its authorized capital and may validly and legally issue as
      fully paid and non-assessable all the shares or other securities which the
      holder of such Broker Warrant Certificate is entitled to receive on the
      full exercise thereof in accordance with the provisions hereof.

- 7 - 

	 	(g) 	
      For the purposes of this Broker Warrant Certificate,
      “Current Market Price” of a Share at any date shall be calculated as the
      price per Share equal to the weighted average price at which the Shares
      have traded in the principal Canadian stock exchange or, if the Shares are
      not listed, the over-the- counter market, on which the Shares are then
      listed or posted for trading during the 20 consecutive trading days (on
      each of which at least 500 Units are traded in board lots) ending on the
      fifth trading day immediately prior to such date as reported by such
      market or exchange in which the Shares are then trading or quoted. If the
      Shares are not then traded in the over-the-counter market or on a
      recognized Canadian stock exchange, the Current Market Price of the Shares
      shall be fair market value of the Shares as determined by a nationally or
      internationally recognized investment dealer or investment
  banker.

	 	 	 
	 	(h) 	
      In the absence of a resolution of the board of directors
      of the Corporation fixing a record date for any dividend or distribution
      referred to in Section 5(a)(i) or any Rights Offering or Special
      Distribution, the Corporation shall be deemed to have fixed as the record
      date therefor the date on which such dividend or distribution is
      effected.

	 	 	 
	 	(i) 	
      Any question or dispute that at any time or from time to
      time arises with respect to the amount of any adjustment to the Exercise
      Price or other adjustments pursuant to Section 5 shall be conclusively
      determined by a firm of independent chartered accountants (who may be the
      Corporation’s auditors) and shall be binding upon the Corporation and the
      Holder. Notwithstanding the foregoing, such determination shall be subject
      to the prior written approval of the principal Canadian stock exchange or
      over-the-counter market on which the Shares are then listed or quoted for
      trading. In the event that any such determination is made, the Corporation
      shall notify the Holder in the manner contemplated in Section 19
      describing such determination.

	7. 	
      On the happening of each and every such event set out in
      Section 5, the applicable provisions of this Broker Warrant Certificate,
      including the Exercise Price, shall, ipso facto, be deemed to be
      amended accordingly and the Corporation shall take all necessary action so
      as to comply with such provisions as so amended.

	 	 	 
	8. 	
      In any case in which Section 5 shall require that an
      adjustment shall be effective immediately after a record date for an event
      referred to herein, the Corporation may defer, until the occurrence of
      such an event:

	 	 	 
		(a) 	
      issuing to the holder of any Broker Warrant exercised
      after such record date and before the occurrence of such event, the
      additional Shares issuable upon such exercise by reason of the adjustment
      required by such event, and

	 	 	 
		(b) 	
      delivering to such holder any distributions declared with
      respect to such additional Shares after such Exercise Date and before such
      event;

	 	 	 
			
      provided, however, that the Corporation shall deliver or
      cause to be delivered to such holder, an appropriate instrument evidencing
      such holder’s right, upon the occurrence of the event requiring the
      adjustment, to an adjustment in the Exercise Price or the number of Shares
      purchasable on the exercise of any Broker Warrant and to such
      distributions declared with respect to any additional Shares issuable on
      the exercise of any Broker Warrant.

	 	 	 
	9. 	
      At least 10 Business Days prior to the effective date or
      record date, as the case may be, of any event which requires or might
      require adjustment in any of the subscription rights pursuant to this
      Broker Warrant Certificate, including the Exercise Price and the number of
      Shares which are purchasable upon the exercise thereof, or such longer
      period of notice as the Corporation shall be required to provide holders
      of Shares in respect of any such event, the Corporation shall notify
      the Holder of the particulars of such event and, if determinable, the
      required adjustment and the computation of such adjustment. In case any
      adjustment for which such notice has been given is not then determinable,
      the Corporation shall promptly after such adjustment is determinable
      notify the Holder of the adjustment and the computation of such
      adjustment.

- 8 - 

	10. 	
      The Corporation shall maintain at its principal office a
      register of holders in which shall be entered the names and addresses of
      the holders of the Broker Warrants and of the number of Broker Warrants
      held by them. Such register shall be open at all reasonable times for
      inspection by the Holder. The Corporation shall notify the Holder
      forthwith of any change of address of the principal office of the
      Corporation.

	 	 
	11. 	
      The Corporation shall not be required to issue fractional
      Shares in satisfaction of its obligations hereunder. If any fractional
      interest in a Share would, except for the provisions of this Section 11,
      be deliverable upon the exercise of a Broker Warrant, the Corporation
      shall in lieu of delivering the fractional Shares therefor satisfy the
      right to receive such fractional interest by payment to the holder of such
      Broker Warrant of an amount in cash equal (computed in the case of a
      fraction of a cent to the next lower cent) to the value of the right to
      acquire such fractional interest on the basis of the Current Market Price
      at the Exercise Date.

	 	 
	12. 	
      Subject as herein provided, all or any of the rights
      conferred upon the Holder by the terms hereof may be enforced by the
      Holder by appropriate legal proceedings.

	 	 
	13. 	
      The registered Holder of this Broker Warrant Certificate
      may at any time up to and including the Expiry Time, upon the surrender
      hereof to the Corporation at its principal office, exchange this Broker
      Warrant Certificate for one or more Broker Warrant Certificates entitling
      the Holder to subscribe in the aggregate for the same number of Shares as
      is expressed in this Broker Warrant Certificate. Any Broker Warrant
      Certificate tendered for exchange shall be surrendered to the Corporation
      and cancelled.

	 	 
	14. 	
      If this Broker Warrant Certificate becomes stolen, lost,
      mutilated or destroyed, the Corporation shall, on such terms as it may in
      its discretion acting reasonably impose, issue and deliver to the Holder a
      new Broker Warrant Certificate of like denomination, tenor and date as the
      Broker Warrant Certificate so stolen, lost, mutilated or
  destroyed.

	 	 
	15. 	
      This Broker Warrant Certificate and the Broker Warrants
      represented hereby are non-transferable.

	 	 
	16. 	
      Except as expressly set out herein, the holding of this
      Broker Warrant Certificate or the Broker Warrants represented hereby shall
      not constitute a Holder hereof a holder of Shares nor entitle it to any
      right of interest in respect thereof.

	 	 
	17. 	
      If any one or more of the provisions or parts thereof
      contained in this Broker Warrant Certificate should be or become invalid,
      illegal or unenforceable in any respect in any jurisdiction, the remaining
      provisions or parts thereof contained herein shall be and shall be
      conclusively deemed to be, as to such jurisdiction, severable therefrom
      and:

	 	(a) 	
      the validity, legality or enforceability of such
      remaining provisions or parts thereof shall not in any way be affected or
      impaired by the severance of the provisions or parts thereof severed;
      and

	 	 	 
	 	(b) 	
      the invalidity, illegality or unenforceability of any
      provision or part thereof contained in this Broker Warrant in any
      jurisdiction shall not affect or impair such provision or part thereof or
      any other provisions of this Broker Warrant in any other
    jurisdiction.

	18. 	
      Any notice, document or communication required or
      permitted by this Broker Warrant Certificate to be given by a party hereto
      shall be in writing and is sufficiently given if delivered personally, or
      if sent by prepaid registered mail, or if transmitted by any form of
      recorded telecommunication rested prior to transmission, to such party
      addressed as follows: :

	 	(a) 	
      to the Holder, in the register to be maintained pursuant
      to section 10 hereof; and

- 9 - 

	 	(b) 	
      to the Corporation at:

	 	 	 
	 		
      IntelGenx Technologies Corp.

	 		
      6425 Abrams

	 		
      Ville St-Laurent, Quebec H4S 1X9

	 	 	 
	 		
      Attention:          
       President
      
Telecopier:         
      (514) 331-0436

	19. 	
      Time is of the essence hereof.

	 	 
	20. 	
      This Broker Warrant Certificate shall enure to the
      benefit of the Holder and his heirs, executors, administrators, legal
      personal representatives, permitted assigns and successors is binding upon
      the Corporation and its successors and assigns.

	 	 
	21. 	
      This Broker Warrant Certificate and the Broker Warrants
      represented hereby shall be governed by the laws of the State of Delaware
      and the federal laws of the United States of America applicable
      therein.

[SIGNATURE PAGE FOLLOWS] 

- 10 - 

          IN
WITNESS WHEREOF this Broker Warrant Certificate has been executed on behalf
of IntelGenx Technologies Corp. as of the ____ day of August, 2010. 

INTELGENX TECHNOLOGIES CORP.

 

By:   
_________________________________________
           
Horst G.
Zerbe 
           
President and Chief Executive Officer 

SUBSCRIPTION NOTICE 

	TO: 	INTELGENX TECHNOLOGIES CORP.
  
	  	6425 Abrams 
	  	Ville St-Laurent, Quebec 
	  	H4S 1X9 

The undersigned registered Holder of
the attached Broker Warrant Certificate, hereby: 

	 	(a) 	
      subscribes for _________________________________ shares
      (“Shares”) of IntelGenx Technologies Corp. at the price per Share in
      Canadian funds equal to CAD$____ (or such adjusted price which may be in
      effect under the provisions of the Broker Warrant Certificate) and in
      payment of the exercise price encloses a certified cheque, bank draft or
      money order in lawful money of Canada payable to the order of IntelGenx
      Technologies Corp. or its successor corporation; and

	 	 	 
	 	(b) 	
      delivers herewith the above-mentioned Broker Warrant
      Certificate entitling the undersigned to subscribe for the above-mentioned
      number of Shares.

	 	 	 
	 		
      The undersigned hereby directs that the said Shares be
      registered as follows:

	  	 	Address(es) 	 	Number of 
	Name(s) in full
	 	(including Postal Code) 	 	Shares 
	 	 	
       

       

       
	 	 

Total:________

(Please print full name in which share certificates are to
be issued. If any of the Shares are to be issued to a person or persons other
than the Holder, the Holder must pay to IntelGenx Technologies Corp. all
requisite taxes or other governmental charges.) 

	 	(c) 	
      certifies either (please check
one):

	 	[   ] 	
      (i) that the undersigned is not a U.S. Person or a person
      in the United States, and is not acquiring any of the Shares hereby
      subscribed for the account or benefit of a U.S. Person or a person in the
      United States, (ii) none of the persons listed in paragraph (b) above is a
      U.S. Person or a person in the United States, and (iii) at the time of
      exercise of the Warrants and execution and delivery of this exercise form
      the undersigned was not in the United States; 

	 	  	
      

	 	[   ] 	
      as of the date hereof there is an effective registration
      statement filed with the United States Securities and Exchange Commission
      covering the issuance of the Shares and the issuance of the Shares will be
      in compliance with all application securities laws of any state of the
      United States; or 

	 	  	
      

	 	[   ] 	
      the undersigned has delivered to the Corporation an
      opinion of counsel (which will not be sufficient unless it is from counsel
      of recognized standing and in form and substance satisfactory to the
      Corporation) to the effect that an exemption from the registration
      requirements of the U.S. Securities Act of 1933, as amended (the “U.S.
      Securities Act”) and applicable state securities laws is available for the
      issuance of the Shares. The undersigned understands that if this box is
      checked, the certificate representing the Shares issued upon exercise of
      the Warrants will bear a legend restricting transfer without registration
      under the U.S. Securities Act and applicable state securities laws unless
      an exemption from such registration requirements is available.
  

For purposes hereof the terms “United
States” and “U.S. Person” shall have the meanings ascribed to them in Regulation
S under the U.S. Securities Act of 1933, as amended. 

DATED this ____________ day of ___________________, 201__. 

_________________________________________

  (Signature of Subscriber) 

_________________________________________

  (Print Name of Subscriber) 

_________________________________________

  _________________________________________

  (Address of Subscriber in full) 

_________________________________________

_________________________________________

The certificates will be mailed by registered mail to the
address appearing in this Subscription Notice.EPOD Solar Inc.: Exhibit 10.1 - Filed by newsfilecorp.com

Exhibit 10.1

STOCK PURCHASE AGREEMENT 

This STOCK PURCHASE AGREEMENT (the “Agreement”), is made as of
this 18th day of August, 2010, by and among Nanotech Industries
International Inc., a corporation organized under the laws of the state of
Nevada, (“Nanotech”), Joseph Kristul (“Kristul”), in his own capacity and on
behalf of all of the holders of capital stock of Nanotech, (individually the
“Seller” and collectively the “Sellers”), and EPOD Solar Inc., a Nevada publicly
traded corporation (“EPOD” or the “Buyer”) (each party to this Agreement
individually referred to as the “Party” and collectively referred to as the
“Parties”).

W I T N E S S E T H : 

WHEREAS, the Parties have
agreed that the Transaction shall consist of the purchase by EPOD of all of the
shares outstanding of Nanotech in exchange for shares of EPOD;

WHEREAS, Buyer wishes to purchase or acquire all of the
issued and outstanding shares of capital stock of Nanotech, from their
respective holders (“Nanotech Shareholders”) as set forth in Schedule
A , all for the consideration and upon the terms and subject to the
conditions hereinafter set forth;

WHEREAS in order to induce
the Nanotech Shareholders to sell the Nanotech Shares (as defined below) to
EPOD, certain holders of common stock of EPOD (“EPOD Shareholders”) have agreed
to surrender for cancellation certain shares of common stock of EPOD held by
them, as set forth in 

Schedule B; and 

WHEREAS, pursuant to certain powers of attorney and
other contractual agreements (the “POA’s”), Kristul has the authority to execute
this agreement on behalf of the Nanotech Shareholders and cause all of the
issued and outstanding shares of capital stock of Nanotech, including the shares
which are not owned by him in his personal capacity, to be transferred and
assigned to the Buyer;

NOW, THEREFORE, the Parties hereto, in consideration of
the mutual promises and other consideration set forth below, the receipt and
adequacy of which is hereby acknowledged, and intending to be legally bound
hereby, do represent, warrant, covenant and agree as follows: 

SECTION 1 

DEFINITIONS 

1.01. 

“Affiliate” means,
as applied to any Person, any other Person directly or indirectly controlling,
controlled by, or under common control with that Person. For the purposes of
this definition, “control” (including with correlative meanings, the terms
“controlling”, “controlled by” and “under common control with”) as applied to
any Person, means the possession, directly or indirectly, of the power to direct
or cause the direction of the management and policies of that Person, whether
through ownership of voting securities or by contract or otherwise. 

1.02. 

“Buyer Indemnified Parties” shall have the meaning
set forth in Section 6.02(a) . 

1.03. 

“Claim” shall mean
any and all administrative or judicial actions, suits, arbitrations, orders,
claims, Liens, notices, notices of violations, investigations, complaints,
requests for information, proceedings, or other communication (written or oral),
whether criminal or civil. 

1.04. 

“Closing” and
“Closing Date” shall have the respective meanings assigned to them in
Section 4.01 hereof. 

1.05. 

“Environmental Law”
means all federal, state, local and foreign environmental, health and safety
Laws, common law orders, decrees, judgments, codes and ordinances and all rules
and regulations promulgated thereunder, civil or criminal, including, without
limitation, Laws relating to emissions, discharges, releases or threatened
releases of Hazardous Material, pollutants, contaminants, chemicals, or
industrial, toxic or hazardous substances or wastes into the environment or
otherwise relating to the manufacture, processing, distribution, use, treatment,
storage, disposal, transport or handling of Hazardous Material, pollutants,
contaminants, chemicals, or industrial, solid, toxic or hazardous substances or
wastes. 

1.06. 

“Governmental or
Regulatory Authority” means any court, tribunal, arbitrator, authority,
agency, commission, official or other instrumentality of the United States and
Canada, any foreign country or any domestic or foreign state, county, city or
other political subdivision, and shall include, without limitation, the
Securities and Exchange Commission, and the various federal, state and foreign
securities regulators and taxation authorities. 

1.07.

“Hazardous Material”
means (i) any petroleum or petroleum products, radioactive materials, asbestos
in any form that is or could become friable, urea formaldehyde foam insulation
and transformers or other equipment that contain dielectric fluid containing
levels of polychlorinated biphenyls (PCBs); (ii) any chemicals, materials,
substances or wastes which are now defined as or included in the definition of
“hazardous substances”, “hazardous wastes,” “hazardous materials,” “extremely
hazardous wastes,” “restricted hazardous wastes,” “toxic substances,” “toxic
pollutants” or words of similar import, under any Environmental Law; and (iii)
any other chemical, material, substance or waste, exposure to which is now
prohibited, limited or regulated by any Governmental or Regulatory Authority.

1.08. 

“Indebtedness” of
any Person means all obligations of such Person (i) for borrowed money, (ii)
evidenced by notes, bonds, debentures or similar instruments, (iii) for the
deferred purchase price of goods or services (other than trade payables or
accruals incurred in the ordinary course of the Business), (iv) under capital
leases and (v) in the nature of guarantees of the obligations described in
clauses (i) through (iv) above of any other Person. 

1.09. 

“Indemnified Party” shall have the meaning set
forth in Section 6.02(c) . 

1.10. 

“Indemnifying Party” shall have the meaning set
forth in Section 6.02(c) . 

1.11.  

“Knowledge” means
the actual knowledge of a Person with respect to any fact, event or condition,
as well as the knowledge that such party reasonably would be expected to have
acquired in the ordinary course of business and the prudent management of its
own affairs. Such definition shall include any form of such term, such as knows,
known, etc., whether or not capitalized, as used in this Agreement with respect
to a party’s awareness of the presence or absence of a fact, event or
condition.

1 

1.12. 

“Laws” means all
laws, statutes, rules, regulations, ordinances and other pronouncements having
the effect of law in Canada, the United States, any foreign country or any
domestic or foreign state, province, county, city or other political subdivision
or of any Governmental or Regulatory Authority. 

1.13. 

“Liability” or
“Liabilities” means all Indebtedness, obligations and other liabilities
(or contingencies that have not yet become liabilities) of a Person (whether
absolute, accrued, contingent (or based upon any contingency), fixed or
otherwise, or whether due or to become due). 

1.14.

 “License” means any
license, permit, certificate of authority, authorization, approvals,
registration, franchise and similar consent granted or issued by any
Governmental or Regulatory Authority. 

1.15.

“Liens” means
claims, pledges, security interests, mortgages, conditional sales agreement,
liens, charges, restrictions, consignments or conditional sales agreements, or
other encumbrances of whatever nature, whether created by statute, Contract,
process of law or otherwise, and whether or not recorded or otherwise perfected.

1.16.  

“Loss” means any and
all damages, fines, fees, penalties, deficiencies, diminution in value of
investment, losses and expenses, including without limitation, interest,
reasonable expenses of investigation, court costs, reasonable fees and expenses
of attorneys, accountants and other experts or other expenses of litigation or
other proceedings or of any claim, default or assessment (such fees and expenses
to include without limitation, all fees and expenses, including, without
limitation, fees and expenses of attorneys, when and as incurred in connection
with (i) the investigation or defense of any Third Party Claims, or (ii)
asserting or disputing any rights under this Agreement against any Party hereto
or otherwise).

1.17. 

“Material Adverse
Effect” means any change or effect of any event or circumstance which,
individually or when taken together with all other changes, effects, events or
circumstances, is or could reasonably be expected to be, materially adverse to
the assets, financial condition, business or results of operation of a Person;
excluding, however, any adverse effect due to changes, after the date of this
Agreement, in conditions affecting the economy generally or the general market
addressed by such Person’s products and/or services. 

1.18. 

“Person” means any
natural person, corporation, general or limited partnership, limited liability
company or partnership, proprietorship, other business organization, estate,
trust, union, association or Governmental or Regulatory Authority. 

1.19. 

“Purchase Price” shall have the meaning set forth
in Section 3.01. 

1.20. 

“Seller Indemnified Parties” shall have the
meaning set forth in Section 6.02(b) . 

1.21. 

“Tax” or
“Taxes” means any and all federal, state, local or foreign taxes, fees,
levies, duties, tariffs, imposts and other governmental charges of any nature
(together with any interest, penalties and additions to tax) including, without
limitation, taxes or other charges on, or with respect to, income, gross
receipts, property, sales, use, capital or net worth. 

2 

1.22. 

“Tax Return” means
any return, report or statement (including any information return) required to
be filed for purposes of a particular Tax. 

1.23.  

“Third Party” shall
mean any Person who is not a party to this Agreement, nor is an Affiliate of any
Party to this Agreement.

1.24. 

“Third Party Claim” shall mean a Claim asserted by
a Third Party. 

SECTION 2 

PURCHASE OF STOCK OF NANOTECH 

Section 2.01. Purchase of Shares of Nanotech. At the
Closing, each of the Nanotech Shareholders respectively, will sell, convey,
transfer and deliver to Buyer, and Buyer will purchase from the Nanotech
Shareholders, for the consideration hereinafter set forth, 33,810,035
(thirty-three million eight hundred and ten thousand and thirty-five) common
shares of Nanotech held by the Nanotech Shareholders as of the Closing Date,
which represents all of the issued and outstanding shares of capital stock of
Nanotech (collectively, the “Nanotech Shares”). All Nanotech Shares shall be
transferred or otherwise conveyed by each of the Nanotech Shareholders, through
duly executed POA’s to Buyer free and clear of all Liabilities, obligations,
Liens, Claims (including Third Party Claims). 

SECTION 3 

PURCHASE PRICE 

3.01. 

 Amount and Payment of
the Purchase Price. In consideration for the Nanotech Shares, Buyer shall
issue to the Nanotech Shareholders an aggregate amount of 3,381,003 (three
million three hundred and eighty-one thousand and three) validly issued, fully
paid and non-assessable new shares of common stock, $0.001 par value per share
(the “Common Stock”), of the Buyer (the “Purchase Price”) on the Closing Date as
set out in Schedule A herein.

3.01a. 

In addition, the EPOD Shareholders and EPOD agree to
cause the cancellation at Closing of a total of 1,028,000 (one million
twenty-eight thousand) shares of common stock of EPOD (“Cancellation Shares”)
held by the EPOD Shareholders as set out in Schedule B. 

3.02. 

 Allocation of Purchase Price. The Parties agree to
allocate the Purchase Price in a manner which causes the least Liabilities for
Taxes under applicable Law, and will collectively execute, prepare, file (or
cause to have prepared and filed) all applicable forms, notices and filings as
are required by applicable Law.

3.03. 

 Employees. The employees of Nanotech shall remain
employed following the Closing Date, upon such terms and conditions as are in
effect immediately prior to the Closing Date. Sellers hereby jointly authorize
Buyer to offer employment to their respective employees, waive any rights they
may have prohibiting such employees from being employed by Buyer, and shall not
offer employment to any employees who have accepted employment with Buyer.
Nothing in this Section 4.03 shall be deemed to be a contract for the benefit of
any employee. Sellers shall use their respective best efforts to assist Buyer in
obtaining the services of all current employees of Sellers that Buyer wishes to
so retain. 

3 

SECTION 4 

CLOSING 

4.01. 

 Closing. The closing
of the purchase and sale of the Nanotech Shares (the “Closing”) shall be held at
the offices of the Buyer or remotely via the exchange of documents and
signatures or at such other time and place as the Parties mutually may agree, on
the first day in which the conditions set forth in this Section 4 have been
satisfied or waived, but in any event no later than 90 (ninety days from the
signing of this Agreement, unless mutually extended in writing by the Parties
(the “Closing Date”).

4.02. 

 Deliveries of
Sellers. Each Seller, as applicable, shall deliver or cause to be delivered
to Buyer at the Closing: 

(a) 

A certified copy
of resolutions, duly adopted by the Boards of Directors and stockholders of
Nanotech, authorizing the transactions contemplated hereby; 

(b) 

Such certificates
issued by the appropriate Governmental or Regulatory Authority as required to
evidence the legal existence and good standing of such Seller; 

(c) 

Nanotech shall deliver or
cause to be delivered to Buyer the following with respect to Nanotech Shares:
(i) stock powers duly endorsed by Nanotech, and otherwise in form acceptable for
transfer of Nanotech Shares on the books of Nanotech, to Buyer; (ii)
certificates representing Nanotech Shares; and (iii) any approvals or consents
required with respect to the transfer of Nanotech Shares to Buyer; and 

(d) 

Such other
closing documents and instruments as Buyer reasonably may require. 

4.03. 

 Deliveries of Buyer.
Buyer shall deliver or cause to be delivered to Sellers at the Closing:

(a) 

The aggregate
amount of 3,381,003 (three million three hundred and eighty-one thousand and
three) shares of Common Stock issued to the Nanotech Shareholders;

(b) 

A certificate,
executed by Buyer’s Secretary certifying the resolutions of Buyer’s Board of
Directors approving the transactions contemplated hereby; and 

(c) 

A certificate
executed on behalf of Buyer by its President, certifying as to Buyer’s
satisfaction of the conditions set forth in Section 4.05(a) and (b). 

4.04. 

 Conditions to the
Buyer’s Obligations. The obligation of the Buyer to consummate the
transactions to be performed by it in connection with the Closing will be
subject to the satisfaction (or waiver by the Buyer, in whole or in part, in
writing) of the following conditions as of the time of the Closing: 

(a) 

Each
representation and warranty set forth in Section 5 will be true and correct in
all material respects at and as of the time of the Closing as though then made,
except for changes expressly required by this Agreement and except for any
representation or warranty that expressly relates to a specific prior date; 

4 

(b) 

Sellers will have
performed and complied in all material respects with all of the covenants and
agreements (considered collectively), and each of the covenants and agreements
(considered individually), required to be performed by the Sellers under this
Agreement or any other agreements, documents and instruments to be entered into
by the Sellers in connection with the transactions contemplated hereby at or
prior to the Closing; 

(c) 

There shall be no
proceeding commenced or threatened against the Buyer or Sellers involving this
Agreement or the transactions contemplated herein or any judgment, decree,
injunction or order which prohibits the consummation of the transactions
contemplated by this Agreement; 

(d) 

Sellers shall
have delivered the Nanotech Shares to the Buyer, free and clear of all
Liabilities, obligations, Liens, Claims (including Third Party Claims, whether
private, governmental or otherwise) and encumbrances, excepting only Assumed
Liabilities;

(e) 

There shall have
been no material adverse change in the condition (financial or otherwise),
results of operations, properties, assets, or Liabilities of Sellers; 

(f)  

Buyer shall have: (i) obtained shareholder approval for the
consummation of the transaction set forth herein; (ii) obtained any and all
other requisite approvals for the consummation of the transaction set forth
herein (iii) made all necessary filings with the SEC;

(g) 

The pro forma consolidated
financial statements of the Buyer shall have been completed in accordance with
the Exchange Act, and the rules and regulations promulgated thereunder, and the
report of independent auditors with respect to such financial statements
completed and submitted; and 

(h) 

Sellers shall
have delivered to the Buyer the items set forth in Section 4.02. 

4.05. 

 Conditions to the
Sellers’ Obligations. The obligation of Sellers to consummate the
transactions to be performed by it in connection with the Closing is subject to
the satisfaction (or waiver by EPOD in writing) of the following conditions as
of the Closing Date: 

(a) 

Each of the
representations and warranties set forth in Section 6 will be true and correct
in all material respects at and as of the time of the Closing as though then
made, except for changes expressly required by this Agreement and except for any
representation or warranty that expressly relates to a specific prior date; 

(b) 

The Buyer will
have performed and complied in all material respects with all of the covenants
and agreements required to be performed by the Buyer under this Agreement at or
prior to the Closing; 

(c) 

There shall be no
proceeding commenced or threatened against the Buyer or Sellers involving this
Agreement or the transactions contemplated herein or any judgment, decree,
injunction or order which prohibits the consummation of the transactions
contemplated by this Agreement. 

5 

(d) 

The pro forma consolidated financial statements of the
Buyer shall have been completed in accordance with the Exchange Act (as defined
below), and the rules and regulations promulgated thereunder, and the report of
independent auditors with respect to such financial statements completed and
submitted. 

(e)  

Buyer shall have: (i) obtained shareholder approval for the
consummation of the transaction set forth herein; (ii) obtained any and all
other requisite approvals for the consummation of the transaction set forth
herein (iii) made all necessary filings with the SEC;

(f) 

The Buyer shall
have delivered to the Sellers the items set forth in Section 4.03. 

(g) 

The Buyer and the EPOD Shareholders shall have surrendered
the Cancellation Shares to EPOD and shall cause the Cancellation shares to be
cancelled. 

4.06. 

 Pre-Closing Covenants.

(a) 

 Operations and Maintenance of the Business. From and
after the date hereof and prior to the Closing, unless the Buyer otherwise
consents in writing or except as set forth expressly herein, Nanotech will
conduct its business only in the ordinary course of business as conducted by it
consistent with past practice.

Furthermore, except as may otherwise be required under this
Agreement, Nanotech shall do any of the following, without the prior written
consent of the Buyer: 

(i) 

enter into any
Contract, agreement or transaction, or incur or permit to be incurred, any
obligation or other Liabilities with respect to or materially affecting its
business and shall not enter into any Contract, agreement or transaction, or
incur or permit to be incurred, any obligation or other Liabilities with respect
to Nanotech Shares;

(ii) 

remove any of its
assets (other than cash and cash equivalents) used in its business by way of
dividend, distribution, withdrawal or any other means;

(iii) 

permit to be
incurred any Lien on any of its assets used in its business; 

(iv) 

increase the
compensation payable or to become payable to any of its employees retained in
connection with its business, or otherwise enter into or alter any employment or
consulting agreement; 

(v) 

commence, enter
into, or alter any profit sharing, deferred compensation, bonus, option or
purchase plan for its interests or other equity securities, pension, retirement
or incentive plan or any fringe benefit plan for its employees retained in
connection with its business; 

(vi)

terminate the
employment of any of its employees retained in connection with its business or
hire or engage any employees or consultants in connection with its business,
except in the ordinary course of its business;

(vii) 

cancel or waive
any of its Claims or rights, with respect to or materially affecting its
business, outside the ordinary course of its business and consistent with past
practice; 

6 

(viii) 

change any
accounting methods used by it in connection with its business, except and solely
to the extent required by applicable generally accepted accounting principles or
Law; 

(ix) 

pay or incur any
obligation or Liability, absolute or contingent, with respect to or materially
affecting its business other than obligations or Liabilities incurred in the
ordinary course of its business and consistent with past practice or purchase
any asset other than in the ordinary course of its business; 

(x) 

make any Tax
election or settle or compromise any Tax Liability which could reasonably be
expected to have an adverse impact on the Taxes payable by Buyer; 

(xi) 

enter into any
joint venture, partnership or other similar arrangement or form any other
material arrangement for the operation of its business; and 

(xii) 

enter into any
binding commitment to do any of the foregoing. 

(b) 

 Consents. Sellers shall use their respective best
efforts to obtain all consents and approvals of Third Parties necessary and
required (including Third Party Claims, whether private, governmental or
otherwise) for the consummation of the transactions contemplated herein. 

(c) 

 Pre-Closing Filings. Buyer shall make all SEC
required filings pertaining to the consummation of this transaction. 

(d) 

 Information. From time to time at the Buyer’s
request, upon reasonable prior notice and at reasonable times during normal
business hours, subject to requirements of Law, the Sellers will provide to
representatives of the Buyer and its agents, employees and accounting, tax,
legal and other advisors (collectively, including the Buyer, the “Investigating
Parties”) access to each Seller’s premises, properties, operations and books and
records, and will cause each of the Sellers respective officers, employees,
representatives, agents and accounting, tax, legal and other advisors to furnish
to Buyer and the Investigating Parties such financial and operating data and
other such information with respect to the Business and the properties of such
Seller as the Investigating Parties shall request. 

(e) 

 Undertaking to Close. Each Party undertakes to cause
the conditions to Buyer’s and Sellers’ respective obligations to consummate the
transactions contemplated by this Agreement to be satisfied including the
preparation, execution and delivery of all agreements and instruments
contemplated hereunder to be executed and delivered by such Party in connection
with or prior to the Closing. 

(f) 

 Schedules. The Sellers shall promptly (and in any
event prior to the Closing) advise Buyer, orally and in writing, of any change
or event having, or which would have (insofar as can be reasonably foreseen), a
Material Adverse Effect or would constitute, or with the passage of time would
constitute, a breach of any representation or warranty of the Sellers contained
in this Agreement. Sellers agree that, with respect to their representations and
warranties made in this Agreement, each of them will have a continuing
obligation to supplement or amend the schedules hereto with respect to any
matter hereafter arising or discovered which, if existing or known at the date
of this Agreement, would have been required to be set forth or described in the
schedules hereto; provided, however, that neither the supplementing or amending
of any schedules by Sellers, nor the discovery of any matters by Buyer in the
course of its investigations, shall be deemed to cure any breach of any
representation or warranty made in this Agreement or to have been disclosed as
of the date of this Agreement. 

7 

(g) 

 Competitive Offers. Sellers shall not, directly or
indirectly, and will cause Nanotech’s officers, employees and Affiliates not to,
solicit or initiate the submission of proposals from, or solicit, encourage,
entertain or enter into arrangements, agreements or understandings with, or
discuss with or furnish information to, any Person (other than the Buyer and the
Investigating Parties) with respect to the acquisition in whatever form of all
or any portion of the Nanotech Shares. 

4.07 

 Change in Control of the Buyer. Upon the signing of
this Agreement, the Parties agree to take the necessary steps to effect any and
all changes to the Officers of EPOD so that the following individuals shall
constitute the officers of EPOD, effective at Closing: (i) Joseph Kristul shall
be appointed as President, CEO and Treasurer, and (ii) Darin Nellis shall be
appointed as Secretary.

In addition, following the Closing, the parties will take such
steps as may be necessary, including the filing of an information statement
pursuant to Section 14(f) of the Exchange Act and Rule 14f-1 thereunder, to
effect any and all changes to the Directors of EPOD, so that the following
individuals shall constitute the directors of EPOD effective as soon as possible
following the Closing: 

	 	Joseph Kristul 	Director 
	 	Alex Trossman 	Director 
	 	Tim Simpson 	Director 

4.08. 

 Effect of Failure to Close. If the Closing of the
transactions contemplated herein does not occur for any reason, then the rights
and obligations of the Parties hereunder shall terminate without any Liability
of any Party to any other Party.

SECTION 5 

REPRESENTATIONS, WARRANTIES AND COVENANTS OF SELLERS 

Sellers hereby represent and warrant to the Buyer as
follows:

5.01. 

Nanotech is a
corporation duly organized, validly existing and in good standing under the laws
of the state of its incorporation. Nanotech has the power and the authority and
all Licenses and permits required by Governmental or Regulatory Authorities to
own and operate its assets and carry on the Business as now being conducted.

5.02.  

The Nanotech Shares held by the Nanotech
Shareholders respectively are owned by each of the Nanotech Shareholders as the
beneficial and recorded owners with good and marketable title thereto, and all
of the Nanotech Shares are free and clear of all mortgages, liens, charges,
security interests, adverse claims, pledges, encumbrances and demands
whatsoever. Kristul, pursuant to the POA’s has the requisite power and authority
to execute and perform this Agreement and all other agreements, documents and
instruments to be entered into on behalf of each of the Nanotech Shareholders,
as applicable, in connection with the transactions contemplated hereby.

5.03. 

The Nanotech Shareholders constitute all of the
stockholders of Nanotech. The execution, delivery and performance of this
Agreement and all other agreements to be entered into in connection with the
transactions contemplated hereby have been duly authorized by the board of
directors of Nanotech, and do not violate or conflict with any provisions of
the organizational documents of Nanotech or any agreement, instrument, Law,
order or regulation to which Nanotech is a party or by which is bound. All
corporate action required to be taken by Nanotech to authorize the execution,
delivery and performance of this Agreement and all other agreements to be
entered into by Nanotech in connection with the transactions contemplated hereby
has been taken, and such execution, delivery and performance do not violate or
conflict with any provisions of the organizational documents of Nanotech or any
agreement, instrument, Law, order or regulation to which Nanotech is a party or
by which Nanotech is bound. No consent, approval or authorization of, or filing
with or notification to, any lender, security holder, Governmental or Regulatory
Authority or other person or entity is required by Nanotech or in connection
with the execution, delivery and performance by Nanotech of this Agreement and
the consummation of the transactions contemplated hereby. 

8 

5.04.  

Nanotech has all requisite corporate power and authority
to execute and deliver this Agreement and all other agreements to be entered
into in connection with the transactions contemplated hereby to which it is a
party, and to perform its obligations hereunder and thereunder. This Agreement
has been, and upon execution and delivery thereof, each of the other agreements
to be entered into in connection with the transactions contemplated hereby to
which the Sellers are a party will be, duly and validly executed and delivered
by the Sellers and the valid and binding obligations of each Seller, enforceable
against such Seller in accordance with their terms, except as enforceability may
be limited by bankruptcy, insolvency, reorganization, moratorium and other
similar laws from time to time in effect affecting the enforcement of creditors’
rights generally, and except as enforcement of remedies may be limited by
general equitable principles.

5.05. 

No Seller has any
Knowledge of any action, suit, litigation or proceeding pending or threatened
against it or otherwise, nor does such Seller know of any basis for any such
action, or of any governmental investigation relating to its business. 

5.06. 

No Seller has
Knowledge of any order, writ, injunction or decree that has been issued by, or
requested of, any court or Governmental or Regulatory Authority which is
against, or binding on such Seller. 

5.07. 

Each Seller has
obtained all required approvals or authorizations of this Agreement and any
other agreements to be entered into in connection with the transactions
contemplated hereby which are required by applicable Laws or otherwise in order
to make this Agreement or any other agreements entered into in connection with
the transactions contemplated hereby binding upon Seller. 

5.08. 

There are no
Liens for any federal, state, county or local franchise, income, excise,
property, business, sales, commercial rent, employment or other Taxes upon
Nanotech. Nanotech has timely filed all federal, foreign, state, county and
local franchise, income, excise, property, business, sales, commercial rent and
employment and other Tax Returns which are required to be filed through the
Closing Date, and has paid, or will pay, all Taxes which are due and payable on
or before the Closing Date.

5.09 

Nanotech, in all
material respects, complied and is in compliance with all applicable Laws,
orders and regulations of any Governmental or Regulatory Authority applicable to
it , its operation of the business, assets or property or its operations
including, without limitation, applicable Laws relating to zoning, building
codes, antitrust, occupational safety and health, Environmental Law, consumer
product safety, product liability, hiring, wages, hours, employee benefit plans
and programs, collective bargaining and withholding and social security taxes.

9 

5.10. 

The
representations and warranties of each Seller contained in this Agreement will
be true and correct on and as of the Closing Date with the same force and effect
as though such representations and warranties had been made on and as of the
Closing Date. 

5.11. 

With respect to
the Common Stock being issued to the Nanotech Shareholders, said shares are
being acquired for investment purposes only and not with a view towards resale
or distribution. Sellers have had an opportunity to ask questions of Buyer and
have done so. The shares of Common Stock are restricted securities that have not
been registered for re-sale pursuant to the Securities Act. Sellers understand
that the Common Stock may not be sold, transferred, assigned or hypothecated or
otherwise distributed to its stockholders as a dividend or otherwise, absent the
effectiveness of a registration statement covering the sale of such Common Stock
or an exemption from the registration requirements the Securities Act.

5.12. 

No Seller has any
Liability or obligation to pay any fees or commissions to any broker, finder or
agent with respect to the transactions contemplated by this Agreement or any
other agreements to be entered into in connection with the transactions
contemplated hereby. 

5.13. 

The Nanotech
Shareholders constitute all of beneficial holders of Nanotech Shares, and
Nanotech Shares constitute all of the issued and outstanding shares of capital
stock of Nanotech. There is no restriction affecting the ability of any of the
Nanotech Shareholders to transfer the title and ownership of Nanotech Shares to
Buyer, and upon delivery of the certificates for Nanotech Shares to Buyer
pursuant to the terms of this Agreement and payment of the Purchase Price at the
Closing, Buyer will acquire record and legal title to such Nanotech Shares, free
and clear of all Liabilities, obligations, Liens, Claims (including Third Party
Claims) and encumbrances. 

5.14 

The officers and
directors of Nanotech are as follows:

	 	Joseph Kristul 	President, Director 
	 	Alex Trossman 	Director 

SECTION 6 

REPRESENTATIONS AND WARRANTIES OF BUYER 

Except as disclosed by Buyer on Buyer’s reports, statements,
schedules, prospectuses, and other documents filed with the Securities and
Exchange Commission (the “SEC”) in accordance with the Securities and Exchange
Act of 1934, as amended, and the rules and regulations promulgated thereunder
(the “Exchange Act”) (collectively, as amended and/or supplemented to date, the
“Securities Filings”), Buyer represents and warrants to the Sellers as follows:

6.01. 

Buyer is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Nevada. 

6.02. 

Buyer is duly
qualified to conduct business under the laws each jurisdiction where such
qualification is necessary, except where the failure to be so qualified would
not have a Material Adverse Effect.

6.03. 

Subject to Section 4.04 (f) a herein, Buyer has all other
requisite corporate power and authority to execute and deliver this Agreement
and all other agreements to be entered into in connection with the transactions contemplated hereby to which it is a
party, and to perform its obligations hereunder and thereunder. The execution
and delivery by Buyer of this Agreement and all other agreements to be entered
into in connection with the transactions contemplated hereby to which it is a
party, and the performance by Buyer of its obligations hereunder and thereunder,
shall be duly and validly authorized by all necessary corporate action on the
part of Buyer, including any vote of stockholders. This Agreement has been, and
upon execution and delivery thereof, each of the other agreements to be entered
into in connection with the transactions contemplated hereby to which Buyer is a
party will be, duly and validly executed and delivered by Buyer and the valid
and binding obligations of Buyer, enforceable against Buyer in accordance with
their terms, except as enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium and other similar laws from time to time in effect
affecting the enforcement of creditors’ rights generally, and except as
enforcement of remedies may be limited by general equitable principles.

10 

6.04 

The Cancellation Shares held by the EPOD
Shareholders respectively are owned by each of the EPOD Shareholders as the
beneficial and recorded owners with good and marketable title thereto, and all
of the EPOD Shares are free and clear of all mortgages, liens, charges, security
interests, adverse claims, pledges, encumbrances and demands whatsoever. Each of
the EPOD Shareholders has the requisite power and authority to cause the
Cancellation Shares to be cancelled at Closing. 

6.05.  

Except as otherwise stated in this Agreement, there is no
additional requirement applicable to Buyer to make any filing with, or to obtain
any permit, authorization, consent or approval of, any governmental entity as a
condition to the lawful consummation by Buyer of the transactions contemplated
pursuant to this Agreement. The execution, delivery and performance of this
Agreement by Buyer does not, and the consummation of the transactions
contemplated hereby will not (with or without the giving of notice, the lapse of
time or both), (i) conflict with or result in any breach of any provision of the
Articles of Incorporation or Bylaws of Buyer, or (ii) violate any applicable
Law, rule, regulation, order, writ, judgment, ordinance, injunction or decree of
any governmental entity to which Buyer is a party or is bound.

6.06  

The authorized capital of
Buyer consists of 75,000,000 shares of Common Stock, of which 2,849,000 shares
are issued and outstanding as of the date of the signing of this Agreement. All
of the outstanding shares of common stock have been duly authorized, are fully
paid and nonassessable and were issued in compliance with all applicable federal
and state securities laws. Buyer holds no treasury stock and no shares of common
stock in its treasury. The rights, privileges and preferences of the common
stock are as stated in Buyer’s Articles of Incorporation and as provided by the
general corporation law of the jurisdiction of the Buyer’s incorporation.

6.07.  

The officers and Directors of EPOD are as follows:

	 	Michael Matvieshen 	CEO and sole Director
  
	 	Satpal Sidhu 	President, Chief Operating Officer and
      Secretary 
	 	Gordon McKenzie 	Treasurer

6.07 

The shares of Common Stock to be issued to the Nanotech
Shareholders in accordance with Section 3.01 will at the time of issuance be,
duly authorized, validly issued and fully paid and non-assessable in all
respects, free from any pre-emptive or other rights, and the issuance thereof
will, at the time of issuance, not violate any agreement or trigger the anti
dilution, right of first refusal, co-sale or similar provisions of any agreement
to which the Buyer is bound. Buyer shall reserve a sufficient number of shares of Common Stock for issuance to the Nanotech
Shareholders. Upon issuance in accordance with the terms of this Agreement, such
shares will be duly authorized, validly issued, fully paid and non-assessable in
all respects, free from any pre-emptive or other rights (other than as entered
into after the date of Closing), and the issuance thereof will not violate any
agreement or trigger the anti-dilution, right of first refusal, co-sale or
similar provisions of any agreement to which Buyer is bound. 

11 

6.08.

All Securities Filings required to be filed by Buyer with
the SEC pursuant to the Exchange Act, along with all exhibits to such annual,
quarterly and other reports as available on the SEC’s EDGAR database website,
are true, correct and complete in all material respects as of the date of filing
thereof, and said reports do not, as of the date of filing thereof, fail
disclose or omit any material fact, agreement or matter relating to the Buyer.

6.09 

There is no
claim, action, suit, proceeding, arbitration, complaint, charge or investigation
pending or to Buyer’s Knowledge, currently threatened against Buyer or, to the
best of Buyer’s Knowledge, threatened against any officer or director of Buyer,
that questions the validity of this Agreement or the right of Buyer to enter
into it, or to consummate the transactions contemplated hereby, or could have or
reasonably be expected to have, either individually or in the aggregate, a
material adverse effect upon the Business. Neither Buyer nor, to the best of
Buyer’s Knowledge, any of its officers or directors, is a party or is named as
subject to the provisions of any order, writ, injunction, judgment or decree of
any court or government agency or instrumentality (in the case of officers or
directors, such as would affect Buyer). There is no action, suit, proceeding or
investigation by Buyer pending or which Buyer intends to initiate. The foregoing
includes, without limitation, actions, suits, proceedings or investigations
pending or threatened in writing (or any basis therefore known to Buyer)
involving the prior employment of any of Buyer’s employees, their services
provided in connection with the Business, or any information or techniques
allegedly proprietary to any of their former employers, or their obligations
under any agreements with prior employers. 

6.10. 

Except as
expressly set forth in this Section 6, Buyer makes no other representation or
warranty with respect to the transactions contemplated by this Agreement or
other agreements to be entered into in connection with the transactions
contemplated hereby. 

SECTION 7 

SURVIVAL OF REPRESENTATIONS AND WARRANTIES;
INDEMNIFICATION 

7.01 

 Survival of Representations and Warranties. All of
Buyer’s representations and warranties in this Agreement or in any other
agreements to be entered into in connection with the transactions contemplated
hereby to which it is a party, and all of Sellers’ representations and
warranties in this Agreement, in any other agreements to be entered into in
connection with the transactions contemplated hereby, or in any instrument
delivered pursuant hereto or thereto, shall survive the Closing Date and
continue until the date which is 12 (twelve) months after the Closing Date;
provided, however, that (i) any claim based on fraud shall survive indefinitely,
(ii) any claim for violation of the representations and warranties with respect
to Taxes, employee matters or Environmental Law shall survive until the
expiration of the applicable statute of limitations applicable to any claim or
right of action related thereto, (iii) the covenants and agreements contained in
this Agreement and the other agreements to be entered into in connection with
the transactions contemplated hereby and to be performed at the Closing Date
will survive until fully performed in accordance with their terms, and (iv) any
claim for indemnity asserted pursuant to Section 7.02 shall, if made within the
applicable time period set forth above with respect to an accrued Liability,
survive indefinitely. However, no claim for indemnity may be asserted under Section 7.02 unless notice of
such claim is given to Nanotech or Buyer, as the case may be, prior to the
appropriate period(s) specified in the preceding sentence. 

12 

7.02 

 Indemnification. 

(a) 

EPOD agrees, from and after the Closing Date, for the
appropriate period(s) specified in Section 7.01, above, to indemnify and hold
Buyer and its officers, directors, agents or Affiliates and their respective
successors and assigns (the “Buyer Indemnified Parties”), harmless from and
against any Loss incurred by any Buyer Indemnified Party, directly or
indirectly, resulting from (i) noncompliance with any applicable bulk sales or
transfer Law, (ii) any Liability or Contract of, or Claim against, a Seller,
whether contingent or absolute, direct or indirect, known or unknown, matured or
unmatured (including but not limited to Liabilities for Taxes), (iii) any
Liability or Claim arising in any way from any service rendered, or action taken
by, or relating to the operations of, a Seller prior to the Closing Date, (iv)
any Liability or Claim under any Environmental Laws relating to any event,
action or failure to act which occurred prior to the Closing Date, or (v) the
breach or inaccuracy of or failure to comply with, or the existence of any facts
resulting in the inaccuracy of, any of the warranties, representations,
conditions, covenants or agreements of a Seller contained in this Agreement or
in any agreement or document delivered pursuant hereto or in connection
herewith, or arising out of the consummation of the transactions contemplated
hereby. 

(b) 

Buyer agrees from and after the Closing Date, for the
appropriate period(s) specified in Section 7.01, above, to indemnify and hold
Sellers and their respective Affiliates, successors and assigns (the “Seller
Indemnified Parties”) harmless from and against any Loss incurred by any Seller
Indemnified Party directly or indirectly resulting from (i) any Liability or
Claim arising in any way from any service rendered, or action taken by, or
relating to the operations of, Buyer after the Closing Date, (ii) any Liability
or Claim under any Environmental Laws relating to any event, action or failure
to act which occurs after the Closing Date, or (iii) any Claim arising out of
Buyer’s breach, failure to fully repay and satisfy, default in or failure to
comply with the terms of, the Assumed Liabilities or any breach of any
warranties, representations, conditions, covenants or agreements of Buyer
contained in this Agreement to which the Buyer is a party, or in any other
agreement, certificate or document delivered pursuant to or in connection with
this Agreement or arising out of the Closing of the transactions contemplated
hereby. 

(c)  

If any Third Party shall notify any party (the “Indemnified
Party”) with respect to any matter which may give rise to a claim for
indemnification against any other party (the “Indemnifying Party”) under this
Section 7, then the Indemnified Party shall notify each Indemnifying Party
thereof promptly; provided, however, that no delay on the part of the
Indemnified Party in notifying any Indemnifying Party shall relieve the
Indemnifying Party from any Liability or obligation hereunder unless (and then
solely to the extent) the Indemnifying Party thereby is materially damaged. In
the event any Indemnifying Party notifies the Indemnified Party within thirty
(30) days after the Indemnified Party has given notice of the matter that the
Indemnifying Party is assuming the defense thereof, (i) the Indemnifying Party
will defend the Indemnified Party against the matter with counsel of its choice
reasonably satisfactory to the Indemnified Party, (ii) the Indemnified Party may
retain separate co-counsel (at its cost), (iii) the Indemnified Party will not
consent to the entry of any judgment or enter into any settlement with respect
to the matter without the written consent of the Indemnifying Party (not to be
withheld unreasonably), and (iv) the Indemnifying Party will not consent to the
entry of any judgment with respect to the matter, or enter into any settlement
which does not include a provision whereby the plaintiff or claimant in the
matter releases the Indemnified Party from all Liability with respect thereto,
without the written consent of the Indemnified Party (not to be withheld
unreasonably).

13 

In the event the Indemnifying Party fails to assume the defense
of the matter as provided herein within thirty (30) days after the Indemnified
Party has given notice thereof, the Indemnified Party may defend against, or
enter into any settlement with respect to, the matter in any manner it
reasonably may deem appropriate. 

(d) 

After the Closing Date, the right of indemnification under
this Section 7 shall be the sole and exclusive remedy available to any Party for
any claim or cause of action arising under this Agreement or other agreements to
be entered into in connection with the transactions contemplated hereby in
connection with any breach of any representation, warranty, covenant or
provision of this Agreement this Agreement, other agreements to be entered into
in connection with the transactions contemplated hereby or otherwise; provided,
however, that this exclusive remedy does not preclude a Party from bringing an
action for specific performance or other equitable remedy to require a party to
perform its obligations under this Agreement. Each Party expressly waives any
rights it may have to make a claim against the other pursuant to any
constitutional, statutory, or common law authorities. The provisions of this
Section 7.02(d) shall not apply to claims arising out of or relating to the
fraud, gross negligence or willful misconduct of the Parties. 

SECTION 8 

PRESERVATION OF BOOKS AND RECORDS 

8.01 

For a period of 3
(three) years after the Closing date, Buyer shall preserve the books and records
of Nanotech delivered to Buyer; and Sellers shall similarly make available to
Buyer any records which Buyer permits Sellers to retain; each Party will make
such books and records available to the other Party at all reasonable times and
permit the other Party to make extracts from or copies of all such records. 

SECTION 9 

CERTAIN OTHER COVENANTS AND AGREEMENTS 

9.01. 

 Further Assurances. Upon the request of either
Party hereto, the other Party will execute and deliver to the requesting Party,
or such Party’s nominee, all such instruments and documents of further assurance
or otherwise, and will do any and all such acts and things as may reasonably be
required to carry out the obligations of such Party hereunder and to more
effectively consummate the transactions contemplated hereby, including, without
limitation, submitting information required by a Governmental or Regulatory
Authority, obtaining all consents and approvals from Third Parties, under
leases, agreements and other Contracts. 

9.02. 

 Quotation. Buyer shall use its best efforts to
maintain the eligibility for quotation of the Common Stock on the over the
counter bulletin board. 

9.03. 

 SEC Reports. Buyer shall file with the SEC all
reports that are required to be filed pursuant to the Exchange Act with respect
to this Agreement and the transactions contemplated hereby. 

SECTION 10 

MISCELLANEOUS 

14 

10.01. 

 Governing Law. This Agreement shall be construed
and interpreted in accordance with the laws of the State of Nevada shall be
enforceable exclusively in the courts thereof.

10.02. 

 Modification. This Agreement may be modified or
amended, and the requirements of any provision hereof may be waived, with the
mutual consent of Sellers and Buyer by written instrument signed by them or
their respective successors or assigns in any manner deemed necessary or
appropriate by them. 

10.03. 

 Binding Nature. This Agreement shall be binding
unto the Parties and may only be terminated by: (i) the Buyer in the event of a
breach of any of the obligations of the Sellers under Sections 4.02 and 4.04
herein, or (ii) by Nanotech in the event of a breach of any of the obligations
of the Buyer under Sections 4.04 and 4.05 herein. 

10.04. 

 Counterparts. This Agreement may be executed in
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. 

10.05. 

 Notices. Any notice or other communication
hereunder may be sent by any means (including facsimile or email or other
electronic means, provided that receipt thereof is acknowledged and confirmed by
the recipient) and shall be effective upon receipt; except that, if sent via
domestic certified mail or via international overnight courier such as Federal
Express, said notice shall be conclusively deemed to have been received by a
Party hereto and be effective on the earlier of (a) the actual date of receipt,
or, if earlier, (b) the third business day following the date given to the post
office or courier for delivery. In addition to such notices and communications
as shall be addressed to such Party at the address set forth at the outset of
this Agreement (or such other address as such Party shall specify to the other
Party in writing), mandatory copies, sent in such manner, shall be delivered to
the additional addressees set forth below: 

	As to Sellers: 	Nanotech Industries International Inc.
    
	  	950 John Daly blvd, Suite 260 
	  	Daly City, CA 94015 
	  	  
	  	Joseph Kristul 
	  	C/O Nanotech Industries International
      Inc. 
	  	950 John Daly blvd, Suite 260 
	  	Daly City, CA 94015 
	  	  
	As to Buyer: 	EPOD Solar Inc 
	  	5 – 215 Neave Road 
	  	Kelowna British Columbia, Canada V1V 2L9
    
	  	Attn: Michael Matvieshen, President
  

10.06. 

 Entire Agreement. This Agreement, together with
its schedules, exhibits and the other agreements to be entered into in
connection with the transactions contemplated hereby, constitutes the entire
understanding among the Parties and supersedes all other understandings and
agreements, oral or written, with respect to the subject matter hereof. 

10.07. 

 Headings. The descriptive headings of the several
sections and paragraphs of this Agreement are inserted for convenience only and
do not constitute a part of this Agreement. 

15 

10.08. Equitable Remedies. In the event that any Party
to this Agreement shall default in the performance of any obligation, covenant
or agreement hereunder, the other Parties to this Agreement shall, in addition
to all other remedies which may be available to it, be entitled to injunctive
and equitable relief, including without limitation specific performance, and
shall be entitled to recover from the defaulting Party or Parties its costs and
expenses (including reasonable attorneys’ fees) incurred by it in securing such
injunctive or equitable relief. 

10.09. Severability. In the event that any provision of
this Agreement shall be held to be invalid or unenforceable by a court of
competent jurisdiction, the remainder of this Agreement should remain in full
force and effect and be interpreted as if such invalid or unenforceable
provision had not been a part hereof; provided, however, if any particular
portion of this Agreement shall be adjudicated invalid or unenforceable by
reason of the length of time or scope of applicability provided for herein, this
Agreement shall be deemed amended to diminish such time and/or reduce such scope
to the longest enforceable time and the broadest enforceable scope of
applicability. 

10.10. Assignment. Buyer shall be entitled to assign all
or part of its rights, title and interest under this Agreement to an Affiliate;
provided that such Affiliate shall assume the corresponding obligations of Buyer
under this Agreement. A copy of any assignment made hereunder shall be promptly
forwarded to EPOD. Sellers may not assign all or any part of their respective
rights, title and interest under this Agreement without the prior written
consent of Buyer. 

10.11. Successors and Assigns. This Agreement shall be
binding upon and inure to the benefit of the Parties herein and their successors
and permitted assigns. 

10.12. Publicity. No Party shall not issue nor cause the
publication of any press release or other announcement with respect to this
Agreement or the transactions contemplated hereby without the consent of the
other Parties, which consent shall not be unreasonably withheld, except where
such release or announcement is required by applicable Law or the rules of any
stock exchange, stock market or Governmental or Regulatory Authority having
authority over any Party.

(Signature page follows.) 

16 

IN WITNESS WHEREOF, the Parties
have executed this Agreement as of the date first above written. 

	SELLERS: 
	  
	NANOTECH INDUSTRIES INTERNATIONAL INC. 
	By:/s/: Joseph
      Kristul                  
      
	Name: Joseph Kristul 
	Its: Chief Executive Officer 
	  
	  
	JOSEPH KRISTUL 
	  
	/s/: Joseph
      Kristul                       
      
	  
	  
	BUYER: 
	  
	EPOD SOLAR INC. 
	By: /s/: Michael
      Matvieshen         
	Name: Michael Matvieshen 
	Its: President 

SCHEDULE A 

Nanotech Shareholders and Share Exchanges 

SCHEDULE B 

EPOD Shareholders 

	
NAME OF HOLDER 	
SHARES HELD 	SHARES TO BE 
CANCELLED 	SHARES HELD POST
      
CANCELLATION 
	Michael Matvieshen 	408,000 	408,000 	0 
	M124 BC Ltd. 	200,000 	125,000 	75,000 
	Doug Sereda 	165,000 	165,000 	0 
	Peter Schriber 	165,000 	165,000 	0
  
	Satpal Sidhu 	165,000 	165,000 	0

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}]]